section name header

Information

Synonym/Acronym

iron: Fe; iron-binding capacity and iron saturation: TIBC, Fe Sat; transferrin: siderophilin, TRF.

Rationale

To monitor and assess iron levels related to blood loss, dietary intake and metabolism, storage disorders, and replacement therapy. To assist in diagnosing types of anemia such as iron deficiency.

Patient Preparation

Instruct the patient to fast for at least 12 hr before specimen collection for iron or transferrin and, with medical direction, to refrain from taking iron-containing medicines before specimen collection. There are no food, fluid, activity, or medication restrictions unless by medical direction for the TIBC and iron saturation. Specimen collection for iron studies should be delayed for several days after blood transfusion. Protocols may vary among facilities.

Normal Findings

Method: Spectrophotometry for iron and TIBC; nephelometry for transferrin.

Iron
AgeConventional UnitsSI Units (Conventional Units × 0.179)
Newborn100–250 ug/dL17.9–44.8 micromol/L
Infant40–105 ug/dL7.2–18.8 micromol/L
Child50–120 ug/mL9–21.5 micromol/L
11 yr–adult
Male45–182 ug/dL8.1–32.6 micromol/L
Female28–170 ug/dL5–30.4 micromol/L

Values tend to decrease in older adults.

TestConventional UnitsSI Units (Conventional Units × 0.179)
TIBC250–450 mcg/dL45–81 micromol/L
Transferrin-iron saturation %20%–50%20%–50%
Conventional UnitsSI Units (Conventional Units × 0.01)
Transferrin (direct measurement)200–360 mg/dL2–3.6 g/L
The percentage of transferrin saturated with iron !!Calculator!!can be calculated as either (serum iron/TIBC value) × 100 or (serum iron × 100%)/TIBC.

Critical Findings and Potential Interventions

Iron

Timely notification to the requesting health-care provider (HCP) of any critical findings and related symptoms is a role expectation of the professional nurse. A listing of these findings varies among facilities.

Intervention may include chelation therapy by administration of deferoxamine mesylate (Desferal).

Overview

(Study type: Blood collected in a gold-, red-, or red/gray-top tube; related body system: Circulatory/hematopoietic system.)

Iron plays a principal role in erythropoiesis, the formation and maturation of RBCs, and is required for Hgb synthesis. The human body contains between 4 and 5 g of iron, about 65% of which is present in hemoglobin and 3% of which is present in myoglobin, the oxygen storage protein found in skeletal and cardiac muscle. A small amount is also found in cellular enzymes that catalyze the oxidation and reduction of iron. Excess iron is stored in the liver and spleen as ferritin and hemosiderin. Any iron present in the serum is in transit between the alimentary tract, the bone marrow, and available iron storage forms. Sixty to seventy percent of the body’s iron is carried by its specific transport protein, transferrin. TIBC and transferrin are sometimes referred to interchangeably, even though other proteins carry iron and contribute to the TIBC. For additional information about stored iron, refer to the study titled “Ferritin.”

Transferrin is a glycoprotein formed in the liver. Its role is the transportation of iron obtained from dietary intake or RBC breakdown; normally, one-third of available transferrin is saturated. Inadequate transferrin levels can lead to impaired Hgb synthesis and anemia. Transferrin is subject to diurnal variation, and it is responsible for the variation in levels of serum iron throughout the day. Normally, iron enters the body by oral ingestion; only 10% is absorbed, but as much as 20% to 30% can be absorbed in patients with iron-deficiency anemia. Unbound iron is highly toxic, but there is generally an excess of transferrin available to prevent the buildup of unbound iron in the circulation. Iron overload is as clinically significant as iron deficiency. An example of acute iron overload is the accidental poisoning of children caused by excessive intake of iron-containing multivitamins. Chronic iron overload can occur in patients receiving serial therapeutic transfusions of RBCs over time for treatment of various cancers, hemoglobinopathies such as sickle cell anemia, the thalassemias, and other hemolytic anemias.

Indications

Interfering Factors

Other Considerations

  • Gross hemolysis can interfere with iron test results.
  • Transferrin levels are subject to diurnal variation and should be collected in the morning, when levels are highest.

Potential Medical Diagnosis: Clinical Significance of Results

Summary of the Relationship Between Serum Iron, TIBC, Transferrin, % Iron Saturation, and Ferritin in Select Circumstances
IronTIBCTransferrin% SaturationFerritin (Stored Iron)
Iron-deficiency (anemia)DecreasedIncreasedIncreasedDecreasedDecreased
Chronic etiology (cancer, infection, liver disease)DecreasedDecreasedDecreasedNormalNormal/increased
Hemolytic (anemia)IncreasedNormal/decreasedNormal/decreasedIncreasedIncreased
Iron overload/hemochromatosisIncreasedDecreasedDecreasedIncreasedIncreased
Iron overload/therapy/poisoningIncreasedNormal/decreasedDecreasedIncreasedNormal

Increased In

Iron

  • Acute iron poisoning (children) (related to excessive intake)
  • Acute leukemia
  • Acute liver disease (including hepatitis) (possibly related to decrease in synthesis of iron storage proteins by damaged liver; iron accumulates and levels increase)
  • Aplastic anemia (related to repeated blood transfusions)
  • Excessive iron therapy (related to excessive intake)
  • Hemochromatosis (inherited disorder of iron overload; the iron is not excreted in proportion to the rate of accumulation)
  • Hemolytic anemias (related to release of iron from lysed RBCs)
  • Lead toxicity (lead can biologically mimic iron, displace it, and release it into circulation where its concentration increases)
  • Nephritis (related to decreased renal excretion; accumulation in blood)
  • Pernicious anemias (PAs) (achlorhydria associated with PA prevents absorption of dietary iron, and it accumulates in the blood)
  • Sideroblastic anemias (enzyme disorder prevents iron from being incorporated into Hgb, and it accumulates in the blood)
  • Thalassemia (treatment for some types of thalassemia include blood transfusions, which can lead to iron overload)
  • Transfusions (repeated)
  • Vitamin B6 deficiency (this vitamin is essential to Hgb formation; deficiency prevents iron from being incorporated into Hgb, and it accumulates in the blood)

TIBC and Transferrin

  • Estrogen therapy (estrogen stimulates the liver to produce transferrin)
  • Hypochromic (iron-deficiency) anemias (insufficient circulating iron levels to saturate binding sites)
  • Pregnancy (the liver produces transferrin in response to anemia of pregnancy)

Decreased In

Iron

  • Acute and chronic infection (iron is a nutrient for invading organisms)
  • Cancer (related to depletion of iron stores)
  • Chronic blood loss (gastrointestinal [GI], uterine) (blood contains iron incorporated in Hgb)
  • Dietary deficiency
  • Hypothyroidism (pathophysiology is unclear)
  • Intestinal malabsorption
  • Iron-deficiency anemia (related to depletion of iron stores)
  • Nephrosis (anemia is common in people with kidney disease; fewer RBCs are made because of a deficiency of erythropoietin related to the damaged kidneys, blood can be lost in dialysis, and iron intake may be lower due to lack of appetite)
  • Postoperative state
  • Pregnancy (related to depletion of iron stores by developing fetus)
  • Protein malnutrition (kwashiorkor) (protein is required to form transport proteins, RBCs, and Hgb)

TIBC and Transferrin

  • Acute or chronic infection (transferrin is a negative acute-phase reactant protein whose levels decrease in response to inflammation)
  • Cancer (especially of the gastrointestinal [GI] tract) (related to malnutrition)
  • Hemochromatosis (occurs early in the disease as intestinal absorption of iron available for binding increases)
  • Hemolytic anemias (transferrin becomes saturated, and the iron-binding capacity is significantly decreased)
  • Kidney disease (transferrin is a negative acute-phase reactant protein that demonstrates decreased levels during periods of inflammation)
  • Liver disease or damage (related to decreased synthesis of transferrin in the liver)
  • Protein depletion (transferrin contributes to the total protein concentration and will reflect a decrease in protein depletion)
  • Sideroblastic anemias (transferrin becomes saturated, and the iron-binding capacity is significantly decreased)
  • Thalassemia (transferrin becomes saturated, and the iron-binding capacity is significantly decreased)

Nursing Implications

Potential Problems: Assessment & Nursing Diagnosis/Analysis

ProblemsSigns and Symptoms
Bleeding (blood loss—related to heavy menses, disease process with chronic blood loss [GI ulcer, malignancy], overuse of NSAIDs)Altered level of consciousness, hypotension, increased heart rate, decreased Hgb and Hct, decreased serum iron, capillary refill greater than 3 sec, cool extremities, poor dietary selections
Tissue perfusion (inadequate cerebral, peripheral, renal—related to inadequate cellular oxygen associated with unhealthy RBCs secondary to iron deficiency)Confusion, altered mental status, headaches, dizziness, visual disturbances, hypotension, cool extremities, capillary refill greater than 3 sec, weak pedal pulses, altered level of consciousness, decreased urine output

Before the Study: Planning and Implementation

Teaching the Patient What to Expect

  • Explain that a blood sample is needed for the test.
  • Discuss how this test can assist in evaluating anemia and the amount of iron in the blood.

After the Study: Implementation & Evaluation Potential Nursing Actions

Treatment Considerations

  • Resume usual diet, fluids, medications, or activity, as directed by the HCP.
  • Fatigue can be a problem. Symptoms of fatigue include verbalization of fatigue, altered ability to perform activities of daily living due to lack of energy, shortness of breath with exertion, increasingly frequent rest periods, presence of fatigue after sleep, inability to adhere to daily routine, altered level of concentration, complaints of tiredness. Monitor and trend CBC, Hgb, Hct, and iron.
  • Interventions/actions related to fatigue include the following: Monitor for shortness of breath. Administer ordered oxygen with use of pulse oximetry. Assess for medical or psychological factors contributing to fatigue. Prioritize and bundle activities to conserve energy. Encourage frequent rest periods. Assess the ability to perform self-care, and assist as needed. Assess for adequate nutritional intake of iron-rich foods. Administer ordered blood and blood products and prescribed iron supplements as ordered. Monitor urine, stool, and sputum for bleeding.

Bleeding

  • Facilitate management of bleeding.
  • Interventions/actions related to bleeding include the following: Assess the effects of blood loss by monitoring serum iron. Identify the cause of chronic blood loss, and assess stool for blood. Administer ordered blood or blood products and prescribed iron. Consider a dietary consult; assess for iron-rich foods and foods that inhibit absorption of iron. Monitor and trend vital signs.

Tissue Perfusion

  • Facilitate management of inadequate tissue perfusion, as blood loss can be a contributing factor.
  • Interventions/actions related to inadequate tissue perfusion include the following: Monitor blood pressure. Assess for dizziness. Check skin temperature for warmth. Assess capillary refill and pulses. Monitor level of consciousness. Monitor urine output (to be in excess of 30 mL/hr). Ensure adequate fluid intake or administer ordered IV fluids. Administer ordered iron supplements.

Nutritional Considerations

  • There are numerous factors that affect the absorption of iron, enhancing or decreasing absorption, regardless of the original content of the iron-containing dietary source.
  • Explain to those with abnormally elevated or abnormally decreased iron levels the importance of reading food labels. Foods high in iron include meats (especially liver), eggs, grains, and green leafy vegetables.
  • Note: Animal liver (e.g. beef, chicken, deer, lamb) is a nutrient-dense food. Micronutrients, with the exception of vitamin D, are not produced by the body; they must be obtained from dietary sources. Liver is a rich source of vitamins and minerals, most notably providing significant amounts of iron, copper, folate, vitamin A, and vitamin B12. Regularly eating large amounts of animal liver can result in vitamin A toxicity and/or damage to the patient’s liver. The general recommendation commonly given by health-care providers to adult patients is to consume no more than one to three and a half ounces (28 to 100 g) of liver, once a week. Recommended portions depend on age and gender. Patients should also be aware of vitamin and mineral concentrations contained in dietary supplements that are taken regularly.
  • Explain that iron levels in foods can be increased if foods are cooked in cookware containing iron.
  • Explain how to either increase or avoid intake of iron and iron-rich foods depending on the specific condition. For example, a patient with hemochromatosis or acute pernicious anemia should be educated to avoid foods rich in iron. A patient with iron deficiency anemia should be educated to identify and consume foods rich in iron. Consumption of large amounts of alcohol damages the intestine and allows increased absorption of iron, as does a high intake of calcium and ascorbic acid.
  • Insufficient nutrition can be a problem. Symptoms of insufficient nutrition include unintended weight loss. Current weight is 20% below ideal weight. Pale, dry skin. Dry mucous membranes. Documented inadequate caloric intake. Subcutaneous tissue loss. Hair pulls out easily, paresthesia. Explain that iron absorption after a meal is increased by factors in meat, fish, and poultry.
  • Interventions/actions related to insufficient nutrition include the following: Obtain an accurate nutritional history and assess attitude toward eating. Facilitate a dietary consult to evaluate current eating habits and best method of nutritional supplementation focusing on iron-rich foods. Monitor serum iron, assess swallowing ability, and encourage iron-rich cultural home foods. Explain that iron absorption is decreased by the absence (gastric resection) or diminished presence (use of antacids) of gastric acid. Explain that phytic acids from cereals, tannins from tea and coffee, oxalic acid from vegetables, and minerals such as copper, zinc, and manganese interfere with iron absorption.

Clinical Judgement

  • Consider how to convey the importance of blood transfusion toward health when deemed a medical necessity.

Follow-Up Evaluation and Desired Outcomes

  • Acknowledges contact information provided for the U.S. Department of Agriculture’s resource for nutrition (www.myplate.gov).